BioNote Market Cap

BioNote has a market cap or net worth of 547.35 billion as of August 14, 2025. Its market cap has increased by 30.65% in one year.

Market Cap

547.35B

Enterprise Value

163.16B

Revenue

105.92B

Ranking

n/a

PE Ratio

12.97

Stock Price

5,290.00

Market Cap Chart

Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 547.35B, a decrease of -49.55%. That is a compound annual growth rate of -22.78%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	547.35B	13.87%
Dec 30, 2024	480.68B	10.95%
Dec 28, 2023	433.23B	-50.44%
Dec 29, 2022	874.10B	-19.44%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.45T
Celltrion	38.14T
ALTEOGEN	22.98T
Yuhan	8,383.50B
SK Biopharmaceuticals	7,737.35B
PharmaResearch	7,064.96B
Peptron	6,989.21B
LigaChem Biosciences	5,419.69B

Market Cap Rankings